These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Phosphorylation of phospholamban in intact myocardium. Role of Ca2+-calmodulin-dependent mechanisms. Lindemann JP, Watanabe AM. J Biol Chem; 1985 Apr 10; 260(7):4516-25. PubMed ID: 3156859 [Abstract] [Full Text] [Related]
65. Altered function in atrium of transgenic mice overexpressing triadin 1. Kirchhefer U, Baba HA, Kobayashi YM, Jones LR, Schmitz W, Neumann J. Am J Physiol Heart Circ Physiol; 2002 Oct 10; 283(4):H1334-43. PubMed ID: 12234783 [Abstract] [Full Text] [Related]
67. Maximal inhibition of SERCA2 Ca(2+) affinity by phospholamban in transgenic hearts overexpressing a non-phosphorylatable form of phospholamban. Brittsan AG, Carr AN, Schmidt AG, Kranias EG. J Biol Chem; 2000 Apr 21; 275(16):12129-35. PubMed ID: 10766848 [Abstract] [Full Text] [Related]
68. A novel contractile phenotype with cardiac transgenic expression of the human P2X4 receptor. Hu B, Mei QB, Yao XJ, Smith E, Barry WH, Liang BT. FASEB J; 2001 Dec 21; 15(14):2739-41. PubMed ID: 11606481 [Abstract] [Full Text] [Related]
78. The enhanced contractility in phospholamban deficient mouse hearts is not associated with alterations in (Ca2+)-sensitivity or myosin ATPase-activity of the contractile proteins. Schwinger RH, Brixius K, Savvidou-Zaroti P, Bölck B, Zobel C, Frank K, Kranias EG, Hoischen S, Erdmann E. Basic Res Cardiol; 2000 Feb 25; 95(1):12-8. PubMed ID: 10752541 [Abstract] [Full Text] [Related]